MEDIUM
Cross-site Scripting (XSS) - Reflected in ptrofimov/beanstalk_console
Published Feb 5, 2022
6.1
MEDIUMCVSS 3.1
EPSS 0.87%
Description
Cross-site Scripting (XSS) - Reflected in Packagist ptrofimov/beanstalk_console prior to 1.7.12.
Affected products
-
- Version unspecifiedStatusaffectedConstraints<1.7.12
- Version
Default status is the baseline for the product, each version can override it (e.g. patched versions marked unaffected).
| Vendor | Product | Default status | Versions | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Ptrofimov | Ptrofimov/beanstalk Console | n/a |
|
- < 1.7.12
No data.
No Red Hat product state for this CVE.
No package ranges for this CVE.
Remediation
No remediation recorded yet.
Weaknesses (1)
References (5)
- https://euvd.enisa.europa.eu/vulnerability/EUVD-2022-1017 Advisory
- https://github.com/advisories/GHSA-gj85-pvp5-mvf9 Advisory
- https://github.com/ptrofimov/beanstalk_console/commit/e351c8260ec1d3718d9e475ee57c7e12c47f19da x_refsource_MISCPatchThird Party Advisory
- https://huntr.dev/bounties/9af1c35e-3f74-4c93-a241-e8be01335ec7 x_refsource_CONFIRMExploitPatchThird Party Advisory
- https://nvd.nist.gov/vuln/detail/CVE-2022-0501
| Link | Providers | Tags |
|---|---|---|
| https://euvd.enisa.europa.eu/vulnerability/EUVD-2022-1017 | Advisory | |
| https://github.com/advisories/GHSA-gj85-pvp5-mvf9 | Advisory | |
| https://github.com/ptrofimov/beanstalk_console/commit/e351c8260ec1d3718d9e475ee57c7e12c47f19da | x_refsource_MISCPatchThird Party Advisory | |
| https://huntr.dev/bounties/9af1c35e-3f74-4c93-a241-e8be01335ec7 | x_refsource_CONFIRMExploitPatchThird Party Advisory | |
| https://nvd.nist.gov/vuln/detail/CVE-2022-0501 |
Change history (0)
No recorded changes yet.
Sources
CVE.org / MITRE
Status PUBLISHED
Assigner @huntrdev
Published Feb 5, 2022
Updated Aug 2, 2024
Reserved Feb 4, 2022
Link CVE-2022-0501
CISA Vulnrichment
Updated n/a
ENISA EUVD
EUVD-2022-1017 GHSA-GJ85-PVP5-MVF9 Assigner @huntrdev
Published Feb 5, 2022
Updated Aug 2, 2024
Exploited since n/a
Link EUVD-2022-1017